BioDan Group creates a kind of printed skin for cosmetic testing

BioDan Group

BioDan Group, a Spanish multinational, has just announced the creation of a division for development and research related to the world of 3D printing baptized with the name of BioDan Print. This new company will be responsible for the development of cutting-edge technologies that are related to the world of at bio-skin 3D printing for the testing of cosmetic, dermatological and chemical products that, once on the market, are to be applied to the skin of any person.

Thanks to the creation of this bio-skin by 3D printing, it will be possible to stop using laboratory animals in tests, something that, currently and for quite some time, has been considered as morally unacceptable. In this way, it seems that BioDan Group is advancing following the path of other large multinationals related to this sector, such as the well-known French firm L'Oreal.

BioDan Group is the first Spanish company to create 100% human bio-skin.

With this research and production of bio-skin, the company has become the first Spanish company in create XNUMX% human skin in all its components without having to use, as in any other case, exogenous components, adding to your product the ability to regenerate skin collagen. Today the company has three very different lines of research where it investigates how to generate human skin from a patient to be used by that same patient or for various medical treatments, seeking solutions of ingredients inserted in nanovesicles capable of crossing the layer corneum, the natural barrier of the skin or the generation of bio-skin manufactured using 3D printing technology.

Based on the statements of Alfredo Brisac, current CEO of BioDan Group:

The most important value on which BioDan Group is based is innovation in the regeneration of human organs, a new revolutionized field of medicine in which we can offer new products and cutting-edge services and thus contribute to the advancement of medicine, to the quality of life of patients and the affectivity of the pharmaceutical and cosmetic industries.


The content of the article adheres to our principles of editorial ethics. To report an error click here!.

Be the first to comment

Leave a Comment

Your email address will not be published. Required fields are marked with *

*

*

  1. Responsible for the data: Miguel Ángel Gatón
  2. Purpose of the data: Control SPAM, comment management.
  3. Legitimation: Your consent
  4. Communication of the data: The data will not be communicated to third parties except by legal obligation.
  5. Data storage: Database hosted by Occentus Networks (EU)
  6. Rights: At any time you can limit, recover and delete your information.